ANI Pharmaceuticals

About:

ANI Pharmaceuticals manufactures oral solid dose products, as well as liquids and topicals.

Website: http://www.anipharmaceuticals.com

Top Investors: Citizens Bank

Description:

ANI Pharmaceuticals is a specialty pharmaceuticals industry that develops, manufactures and markets top-quality prescription pharmaceuticals, made in the U.S.A. ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies.

Total Funding Amount:

$582M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Baudette, Minnesota, United States

Founded Date:

1996-08-29

Contact Email:

a(AT)agentfin.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-08-07

IPO Status:

Public

© 2025 bioDAO.ai